ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BLCO vs STAA // NET PROFIT MARGIN

Bausch + Lomb Corporation (NYSE) VS. STAAR Surgical Company (NASDAQ) • 15-METRIC TALLY: BLCO 8 — STAA 1
▲ NET PROFIT MARGIN LEADER: BLCO
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLCO VS. STAA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BLCO STAA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 76.20% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 0.80% -35.00% +35.80 BLCO /roic <GO>
EV/EBITDA & P/E Valuation 29.1x — — TIE /valuation <GO>
Free Cash Flow Yield -0.90% -3.16% +2.26 BLCO /fcf-yield <GO>
Operating Margin 2.20% -38.30% +40.50 BLCO /operating-margins <GO>
Net Profit Margin ACTIVE -7.10% -33.60% +26.50 BLCO /net-margins <GO>
Revenue Growth (YoY) 6.50% -23.70% +30.20 BLCO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.97 7.11 -6.14 STAA /balance-sheet <GO>
Piotroski F-Score Quality 6/9 3/9 +3.00 BLCO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 75.8 65.1 +10.70 BLCO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.06 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 23.0x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $7.29B $1.27B $6.03B BLCO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BLCO REV STAA REV BLCO GROSS % STAA GROSS % BLCO FCF STAA FCF
FY 2025 $5.10B $239.4M — 76.2% -$66.0M -$40.0M
FY 2024 $4.79B $313.9M — 76.3% -$59.0M -$7.7M
FY 2023 $4.15B $322.4M — — -$203.6M $14.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLCO // BETA 1.06
STAA // BETA —